Pyxis Oncology, Inc. (PYXS) Insider Trading
Over the last 3 months, PYXS insiders made 0 open-market buys and 3 sales, a net sale of -$16K (SEC Form 4). Over the last 6 months, 42 institutions increased and 52 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$15.9K
Insider trades by month Buys Sells
Dec
Apr
Mar
Sep
Nov
Mar
Context3-month price +14.1%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 25, 2026 | Metzger Michael Adirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | FLAVIN JOHN Ldirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | Dupont Jakobdirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | Wadhane Jitendraofficer: Prin Fin & Acct Officer | Grant | 109,461 | — |
| Mar 25, 2026 | Wadhane Jitendraofficer: Prin Fin & Acct Officer | Grant | 262,635 | $1.36 |
| Mar 25, 2026 | HUMPHREY RACHELdirector | Sell | 13,896 | $1.03 |
| Mar 25, 2026 | HUMPHREY RACHELdirector | Sell | 200 | $0.97 |
| Mar 25, 2026 | HUMPHREY RACHELdirector | Sell | 1,400 | $0.97 |
| Mar 25, 2026 | Palani Santhoshdirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | HUMPHREY RACHELdirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | Cline Darren Sdirector | Grant | 45,867 | $1.36 |
| Mar 25, 2026 | Lewis-Hall Freda Cdirector | Grant | 45,867 | $1.36 |
| Feb 5, 2026 | Civik Thomasdirector, officer: Interim CEO | Grant | 690,131 | $1.49 |
| Apr 2, 2025 | FLAVIN JOHN Ldirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Sullivan Laradirector, officer: President ,CEO & CMO | Grant | 918,308 | $0.98 |
| Apr 2, 2025 | Metzger Michael Adirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Wadhane Jitendraofficer: SVP, Chief Accounting Officer | Grant | 263,782 | $0.98 |
| Apr 2, 2025 | HUMPHREY RACHELdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Lewis-Hall Freda Cdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Cline Darren Sdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Dupont Jakobdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Palani Santhoshdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Civik Thomasdirector | Grant | 36,979 | $0.98 |
| Apr 2, 2025 | Connealy Pamela Annofficer: CFO & COO | Grant | 414,163 | $0.98 |
| Dec 23, 2024 | Wadhane Jitendraofficer: SVP, Chief Accounting Officer | Grant | 150,000 | $1.67 |
| Dec 23, 2024 | Connealy Pamela Annofficer: CFO & COO | Grant | 310,000 | $1.67 |
| Dec 23, 2024 | Sullivan Laradirector, officer: Chief Executive Officer | Grant | 1,135,000 | $1.67 |
| Nov 27, 2024 | Connealy Pamela Annofficer: CFO & COO | Buy | 5,450 | $2.00 |
| Nov 27, 2024 | Connealy Pamela Annofficer: CFO & COO | Buy | 83,400 | $1.96 |
| Jun 10, 2024 | Metzger Michael Adirector | Grant | 70,683 | $3.97 |
Source: PYXS SEC Form 4 filings, latest Mar 25, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their PYXS positions over the last 6 months (SEC Form 13F).
Increased
42
New positions
33
Reduced
52
Sold out
29
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| PFIZER INC | Unchanged | 7.0M | Feb 12, 2026 |
| PFIZER INC | Unchanged | 7.0M | May 12, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Increased | 5.0M | May 14, 2026 |
| LAURION CAPITAL MANAGEMENT LP | Increased | 4.8M | Feb 17, 2026 |
| GordonMD Global Investments LP | Unchanged | 4.1M | May 15, 2026 |
| GordonMD Global Investments LP | New Position | 4.1M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 2.3M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.0M | May 15, 2026 |
| PALO ALTO INVESTORS LP | Unchanged | 1.0M | Feb 17, 2026 |
| PALO ALTO INVESTORS LP | Reduced | 1.0M | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Increased | 896K | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Increased | 892K | Feb 17, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 889K | May 14, 2026 |
| BLACKROCK, INC. | Increased | 789K | May 13, 2026 |
| JANE STREET GROUP, LLC | Increased | 786K | Feb 12, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.